| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 3,332 | 2,911 | 4,552 | 5,914 | | Cost of Revenue | 2,336 | 1,589 | 1,819 | 2,923 | | | Gross Profit | 996 | 1,322 | 2,733 | 2,991 | | | Operating Expenses | | Research Development | 1,400 | 1,877 | 1,612 | 1,400 | | Selling General and Administrative | 2,525 | 2,709 | 2,643 | 3,093 | | Non Recurring |
-
|
-
|
-
| 50 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,929) | (3,264) | (1,522) | (1,552) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (30) | 45 | (46) | (1,075) | | Earnings Before Interest And Taxes | (2,959) | (3,219) | (1,568) | (2,627) | | Interest Expense | 31 | 23 | 24 | 23 | | Income Before Tax | (2,990) | (3,242) | (1,592) | (2,650) | | Income Tax Expense | 7 | (15) | 4 | (30) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,997) | (3,227) | (1,596) | (2,620) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,997) | (3,227) | (1,596) | (2,620) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,997) | ($3,227) | ($1,596) | ($2,620) |
|
0.51% Nasdaq 
0.09 (4.09%) 
Income Statement
